EUCTR2015-003940-38-ES进行中（未招募）不适用
Plasma level pharmacokinetics study of posaconazole with the sequential use of two oral formulations (oral suspension and solid tablets) in haematology patients with a high risk of invasive mycoses.
Fundación Investigación Biomédica Puerta de Hierro0 个研究点开始时间: 2016年1月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Adult patiens with an indication for antifungal prophylaxis with posaconazole for prolonged severe neutropenia after intensive chemotherapy for acute myeloid leukemia or myelodysplastic syndromes.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Excluded are patients with a history of invasive mycosis, recipients of allogeneic transplantation with or without graft-versus-host disease, with abnormal liver or renal function, prolonged QTc, ECOG >2, pregnant women, or those with some concomitant or previous treatments.
研究者
相似试验
进行中（未招募）
不适用
A Study to Look at the Way the Body Absorbs and Distributes Posaconazole in the Blood and Lungs of Lung Transplant Recipients (PAPAL Study)Invasive fungal infection (IFI) in lung transplant patients with and without cystic fibrosis.MedDRA version: 15.0Level: PTClassification code 10049085Term: Antifungal prophylaxisSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2012-003140-68-GBMSD40
进行中（未招募）
1 期
Exposure to posaconazole given intravenous compared to oral.EUCTR2016-001182-87-NLRadboud University Medical Centre27
进行中（未招募）
1 期
Exposure to posaconazole given intravenous compared to oral.EUCTR2016-001182-87-BERadboud University Medical Centre27
已完成
4 期
Pharmacokinetics of posaconazole given as a single intravenous dose to obese subjects: Dosing Obese with Noxafil® Under a Trial (DONUT).NL-OMON45475Radboud Universitair Medisch Centrum26
已完成
不适用
Pharmacokinetic Evaluation of POSaconazole boosted Fosamprenavir (EPOS)HIVhuman immunodeficiency virus10017528NL-OMON32580niversitair Medisch Centrum Sint Radboud24